Expediency versus efficacy: re-examining the FDA’s accelerated drug approval process

23 June 2022 - It was precisely 30 years ago, in 1992, that the FDA established the accelerated approval program ...

Read more →

HIRA reviews reimbursing antidiabetic combo therapies

15 June 2022 - HIRA has been analysing how new reimbursements for anti-diabetic combination therapies mixing oral SGLT-2 and DPP-4 ...

Read more →

Medicines Australia moves quickly to put HTA system reform high on new Government’s agenda

10 June 2022 - Medicines Australia has moved quickly to ensure that major reform of Australia’s health technology assessment system ...

Read more →

Hope for change after PHARMAC independent review

2 June 2022 - A woman who had her bowel removed while she waited for drugs that would probably have ...

Read more →

TLV reconsiders subsidy of the IL-17 and IL-23 inhibitors

2 June 2022 - The TLV has started a trial for the interleukin 17 and interleukin 23 inhibitors. ...

Read more →

Health Minister urges PHARMAC to focus on equity and collaboration

1 June 2022 - PHARMAC will need to engage more with other parts of the health system and the public - ...

Read more →

Government response to independent PHARMAC review

1 June 2022 - The Government has released its response to the recommendations of the final report of the independent ...

Read more →

Accelerated approval: unfulfilled promises for FDA’s expedited review program

27 May 2022 - As practicing physicians, approval by the U.S. FDA reassures us that the treatments we prescribe our patients ...

Read more →

Where is the PHARMAC review?

28 May 2022 - “It has been three months to the day since the Minister received the PHARMAC review, why ...

Read more →

Review of discount rate in the PBAC Guidelines

25 May 2022 - The Commonwealth has entered into a new Strategic Agreement in relation to reimbursement, health technology assessment ...

Read more →

Medicines Australia puts spotlight on reform priority for the next Government

20 May 2022 - Medicines Australia has set the scene for major health reform by the next Government by alerting ...

Read more →

TLV reconsiders subsidy of CGRP inhibitors

18 May 2022 - TLV has started a review of the CGRP inhibitors. ...

Read more →

Discount rate adjustment for the health of future generations

17 May 2022 - Medicines Australia has released a video detailing the need for Australia to adjust its discount rate ...

Read more →

Calls for Health Minister to release final report from PHARMAC review

11 May 2022 - Health Minister Andrew Little is facing calls to release the final report from a review of ...

Read more →

Next Health Minister must restart the National Medicines Policy Review

10 May 2022 - Medicines Australia has released a video outlining the importance of restarting the National Medicines Policy Review ...

Read more →